BridgeMD
New treatment option for Intermittent Fasting
Official title Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit
ClinicalTrials.gov ID: NCT06330610
What this study is testing
- What it's testing
- This study aims to evaluate the efficiency of intermittent enteral nutrition versus continuous enteral nutrition to prevent from organ failures for patients at the acute phase of sepsis shock with mechanical ventilation in ICU.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient admitted in ICU for less than 48h, with invasive mechanical ventilation predicted for at least 48h, that can undergo nasogastric feeding for...
- Patient under vasopressive drugs
- Adult patients (age ≥ 18 years)
- Informed person who has read and signed their consent
- If the patient is unable to sign their consent (emergency situation), the consent will be signed by a trusted person or a family member, and consent...
You likely can't join if
- Contraindication to enteral nutrition and/or nasogastric tube insertion: esophageal varices and occlusive syndrome
- Artificial enteral nutrition that cannot be initiated within 48 hours of intubation
- Enteral nutrition ongoing for more than one hour at the time of inclusion
- Need for exclusive or supplemental parenteral nutrition
- Moribund patient
- Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection/guardianship or curatorship
See the full eligibility criteria
- Patient admitted in ICU for less than 48h, with invasive mechanical ventilation predicted for at least 48h, that can undergo nasogastric feeding for 7 days.
- Patient under vasopressive drugs
- Adult patients (age ≥ 18 years)
- Informed person who has read and signed their consent
- If the patient is unable to sign their consent (emergency situation), the consent will be signed by a trusted person or a family member, and consent to continue the study will be requested subsequently.
- If the patient is unable to sign their consent (emergency situation) and no trusted person is present, the patient may be included in the study. In this case, consent to continue the study will be requested from a...
- Affiliation to a social security scheme
- No current pregnancy: for women of childbearing age, a beta-HCG blood pregnancy test will be performed upon inclusion; for postmenopausal women, a confirmatory diagnosis must be obtained.
- Contraindication to enteral nutrition and/or nasogastric tube insertion: esophageal varices and occlusive syndrome
- Artificial enteral nutrition that cannot be initiated within 48 hours of intubation
- Enteral nutrition ongoing for more than one hour at the time of inclusion
- Need for exclusive or supplemental parenteral nutrition
- Moribund patient
- Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection/guardianship or curatorship
- Pregnant or breastfeeding woman
The study team makes the final eligibility decision.
Where it's taking place
- Rouen, France, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rouen, France, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.